Iduronate-2-sulfatase: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 33: | Line 33: | ||
{{genetics-stub}} | {{genetics-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 01:44, 11 February 2025
Iduronate-2-sulfatase (I2S) is an enzyme that plays a crucial role in the lysosomes of animals, including humans. It is involved in the breakdown of glycosaminoglycans (GAGs), specifically dermatan sulfate and heparan sulfate.
Function
Iduronate-2-sulfatase is responsible for the hydrolysis of the 2-sulfate groups of the L-iduronate 2-sulfate units of dermatan sulfate and heparan sulfate. These complex molecules are broken down within lysosomes, the 'recycling centers' of cells, where they are degraded and their components are reused by the cell.
Clinical significance
Deficiency of I2S is associated with a rare genetic disorder known as Hunter syndrome (Mucopolysaccharidosis type II). This is an inherited condition in which the body is unable to break down certain complex molecules, leading to a range of symptoms including developmental delay, skeletal abnormalities, and organ enlargement.
Genetics
The gene that encodes I2S is located on the X chromosome, which means that Hunter syndrome is an X-linked recessive condition. This means that males are typically affected, while females are usually carriers of the condition.
Treatment
Treatment for Hunter syndrome involves managing the symptoms and improving quality of life. Enzyme replacement therapy, in which synthetic I2S is administered, can help to break down the accumulated GAGs and alleviate some of the symptoms.
See also
References
<references group="" responsive="1"></references>


